![proANP Metabolism Provides New Insights Into Sacubitril/Valsartan Mode of Action | Circulation Research proANP Metabolism Provides New Insights Into Sacubitril/Valsartan Mode of Action | Circulation Research](https://www.ahajournals.org/cms/asset/a3b8495e-4a15-4d7d-a756-b810101a1ced/circresaha.122.320882.fig08.jpg)
proANP Metabolism Provides New Insights Into Sacubitril/Valsartan Mode of Action | Circulation Research
![Sacubitril/valsartan in heart failure: latest evidence and place in therapy - Edgardo Kaplinsky, 2016 Sacubitril/valsartan in heart failure: latest evidence and place in therapy - Edgardo Kaplinsky, 2016](https://journals.sagepub.com/cms/10.1177/2040622316665350/asset/images/large/10.1177_2040622316665350-fig1.jpeg)
Sacubitril/valsartan in heart failure: latest evidence and place in therapy - Edgardo Kaplinsky, 2016
![Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure | Revista Portuguesa de Cardiologia (English edition) Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure | Revista Portuguesa de Cardiologia (English edition)](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2174204917302374:gr2.jpeg?xkr=ue/ImdikoIMrsJoerZ+w94UphxYc+GPca8Z7OggvdfJQF4SIqTc4zp8SrbcUWBiKS3MUmaOyBgX/+OSVD6Xz3Nj1ubW2HHoj/JiiYNLEZNQC7U+wxSA2Sj2e5vRO9Soc162pv2ggKRG2q+y+PD+I5gY3DHzrRjjpQFnWkxDe16kdQvyISDSYP2exabAov5PYIFWJH56B6wfskrlh7X+0pwMs9h/IyuYXcOxnPLewshkiSyZkDPUd9XVbJjGG3JtJ1CEQTlL+BBmZzwRiVIFBo7enByMFuAoqc1k+zdoyxFk=)
Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure | Revista Portuguesa de Cardiologia (English edition)
![Frontiers | Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review Frontiers | Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review](https://www.frontiersin.org/files/Articles/754499/fcvm-08-754499-HTML/image_m/fcvm-08-754499-g005.jpg)
Frontiers | Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
Office of Clinical Pharmacology Review NDA or BLA Number 207620 Link to EDR \\cdsesub1\evsprod\NDA207620 Submission Date 4/1/201
![Sacubitril/valsartan therapeutic strategy in HFpEF: Clinical insights and perspectives - ScienceDirect Sacubitril/valsartan therapeutic strategy in HFpEF: Clinical insights and perspectives - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0167527318305837-gr1.jpg)
Sacubitril/valsartan therapeutic strategy in HFpEF: Clinical insights and perspectives - ScienceDirect
![The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan | Heart The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan | Heart](https://heart.bmj.com/content/heartjnl/102/17/1342/F4.large.jpg)
The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan | Heart
![Sacubitril/Valsartan in Management of Heart Failure: A Review of Safety, Efficacy and Cost-Effectiveness | Middle East Medical Portal Sacubitril/Valsartan in Management of Heart Failure: A Review of Safety, Efficacy and Cost-Effectiveness | Middle East Medical Portal](http://www.middleeastmedicalportal.com/wp-content/uploads/2020/07/figure-2-3-675x387.jpg)
Sacubitril/Valsartan in Management of Heart Failure: A Review of Safety, Efficacy and Cost-Effectiveness | Middle East Medical Portal
![Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach | npj Systems Biology and Applications Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach | npj Systems Biology and Applications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41540-017-0013-4/MediaObjects/41540_2017_13_Fig3_HTML.jpg)
Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach | npj Systems Biology and Applications
![Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial | Elsevier e-Prints Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial | Elsevier e-Prints](http://ereprints.elsevier.es/system/files/articles/assets/S2213177917303190/1141/fx1.jpg)
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial | Elsevier e-Prints
![Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control - Jelena P. Seferovic, Scott D. Solomon, Ellen W. Seely, 2020 Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control - Jelena P. Seferovic, Scott D. Solomon, Ellen W. Seely, 2020](https://journals.sagepub.com/cms/10.1177/2042018820970444/asset/images/large/10.1177_2042018820970444-fig1.jpeg)